Clinical Trials
5 trialsNCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT03310541 2023-05-06
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00217464 2015-04-16
Fulvestrant in Treating Patients With Recurrent Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00476645 2014-08-05
Fulvestrant in Hormone Refractory Prostate Cancer
Stanford University
Phase 2 Completed
NCT00244998 2013-03-08
Fulvestrant in Treating Patients With Advanced Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed